CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,073,539 | +12.5% | 296,301 | -8.1% | 0.00% | +50.0% |
| Q2 2023 | $7,173,645 | -8.7% | 322,411 | -11.1% | 0.00% | -33.3% |
| Q1 2023 | $7,857,772 | +3.5% | 362,778 | -2.9% | 0.00% | 0.0% |
| Q4 2022 | $7,590,000 | -23.5% | 373,688 | -3.4% | 0.00% | -25.0% |
| Q3 2022 | $9,918,000 | +5.0% | 386,797 | -2.6% | 0.00% | +33.3% |
| Q2 2022 | $9,449,000 | +4.7% | 397,326 | -0.9% | 0.00% | 0.0% |
| Q1 2022 | $9,028,000 | +13.3% | 400,900 | -0.4% | 0.00% | +50.0% |
| Q4 2021 | $7,970,000 | -7.9% | 402,458 | -8.4% | 0.00% | -33.3% |
| Q3 2021 | $8,651,000 | -14.5% | 439,599 | -4.4% | 0.00% | 0.0% |
| Q2 2021 | $10,121,000 | -9.6% | 460,072 | -2.2% | 0.00% | -25.0% |
| Q1 2021 | $11,194,000 | -4.1% | 470,555 | +5.5% | 0.00% | 0.0% |
| Q4 2020 | $11,667,000 | +45.2% | 445,970 | -3.4% | 0.00% | +33.3% |
| Q3 2020 | $8,035,000 | -1.1% | 461,614 | -4.4% | 0.00% | 0.0% |
| Q2 2020 | $8,124,000 | +36.4% | 482,986 | -3.6% | 0.00% | 0.0% |
| Q1 2020 | $5,958,000 | -6.7% | 501,139 | -5.0% | 0.00% | 0.0% |
| Q4 2019 | $6,384,000 | -16.9% | 527,589 | -2.9% | 0.00% | 0.0% |
| Q3 2019 | $7,678,000 | +14.7% | 543,275 | -9.5% | 0.00% | 0.0% |
| Q2 2019 | $6,696,000 | -7.4% | 600,515 | -2.5% | 0.00% | 0.0% |
| Q1 2019 | $7,234,000 | -13.9% | 616,116 | -2.1% | 0.00% | -25.0% |
| Q4 2018 | $8,405,000 | -5.1% | 629,127 | -0.4% | 0.00% | +33.3% |
| Q3 2018 | $8,859,000 | -0.1% | 631,942 | +12.0% | 0.00% | -25.0% |
| Q2 2018 | $8,870,000 | -36.6% | 564,236 | -33.7% | 0.00% | -33.3% |
| Q1 2018 | $13,989,000 | -9.1% | 850,503 | -0.2% | 0.01% | -14.3% |
| Q4 2017 | $15,388,000 | +164.3% | 852,068 | +182.4% | 0.01% | +133.3% |
| Q3 2017 | $5,822,000 | +589.8% | 301,695 | +159.3% | 0.00% | – |
| Q4 2016 | $844,000 | +16780.0% | 116,360 | +3406.9% | 0.00% | – |
| Q3 2013 | $5,000 | -16.7% | 3,318 | 0.0% | 0.00% | – |
| Q2 2013 | $6,000 | – | 3,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |